| The intricate role of CXCR4 in cancer S Chatterjee, BB Azad, S Nimmagadda Advances in cancer research 124, 31-82, 2014 | 673 | 2014 |
| Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity Y Singh, V Kaul, A Mehra, S Chatterjee, S Tousif, VP Dwivedi, M Suar, ... Journal of Biological Chemistry 288 (7), 5056-5061, 2013 | 197 | 2013 |
| A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors S Chatterjee, WG Lesniak, M Gabrielson, A Lisok, B Wharram, ... Oncotarget 7 (9), 10215, 2016 | 194 | 2016 |
| Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner S Chatterjee, VP Dwivedi, Y Singh, I Siddiqui, P Sharma, L Van Kaer, ... PLoS pathogens 7 (11), e1002378, 2011 | 177 | 2011 |
| Rapid PD-L1 detection in tumors with PET using a highly specific peptide S Chatterjee, WG Lesniak, MS Miller, A Lisok, E Sikorska, B Wharram, ... Biochemical and biophysical research communications 483 (1), 258-263, 2017 | 164 | 2017 |
| PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET WG Lesniak, S Chatterjee, M Gabrielson, A Lisok, B Wharram, ... Bioconjugate chemistry 27 (9), 2103-2110, 2016 | 160 | 2016 |
| Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer RA De Silva, D Kumar, A Lisok, S Chatterjee, B Wharram, ... Molecular pharmaceutics 15 (9), 3946-3952, 2018 | 114 | 2018 |
| Peptide-based PET quantifies target engagement of PD-L1 therapeutics D Kumar, A Lisok, E Dahmane, M McCoy, S Shelake, S Chatterjee, V Allaj, ... The Journal of clinical investigation 129 (2), 616-630, 2019 | 110 | 2019 |
| Human cancer cell membrane-coated biomimetic nanoparticles reduce fibroblast-mediated invasion and metastasis and induce T-cells J Jin, B Krishnamachary, JD Barnett, S Chatterjee, D Chang, Y Mironchik, ... ACS applied materials & interfaces 11 (8), 7850-7861, 2019 | 109 | 2019 |
| Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy TJ Gniadek, QK Li, E Tully, S Chatterjee, S Nimmagadda, E Gabrielson Modern Pathology 30 (4), 530-538, 2017 | 108 | 2017 |
| NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes A Singh, A Daemen, D Nickles, SM Jeon, O Foreman, K Sudini, F Gnad, ... Clinical Cancer Research 27 (3), 877-888, 2021 | 96 | 2021 |
| Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function TE Sussan, S Gajghate, S Chatterjee, P Mandke, S McCormick, K Sudini, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 309 (1 …, 2015 | 83 | 2015 |
| Noninvasive imaging of immune checkpoint ligand PD-L1 in tumors and metastases for guiding immunotherapy S Chatterjee, WG Lesniak, S Nimmagadda Molecular imaging 16, 1536012117718459, 2017 | 67 | 2017 |
| Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1β production in dendritic cells VP Dwivedi, D Bhattacharya, S Chatterjee, DVR Prasad, ... Journal of Biological Chemistry 287 (40), 33656-33663, 2012 | 61 | 2012 |
| Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide WG Lesniak, RC Mease, S Chatterjee, D Kumar, A Lisok, B Wharram, ... Molecular imaging 18, 1536012119852189, 2019 | 60 | 2019 |
| A PSMA-targeted theranostic agent for photodynamic therapy Y Chen, S Chatterjee, A Lisok, I Minn, M Pullambhatla, B Wharram, ... Journal of Photochemistry and Photobiology B: Biology 167, 111-116, 2017 | 49 | 2017 |
| A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts BB Azad, S Chatterjee, WG Lesniak, A Lisok, M Pullambhatla, ... Oncotarget 7 (11), 12344, 2016 | 46 | 2016 |
| Targeted imaging of the atypical chemokine receptor 3 (ACKR3/CXCR7) in human cancer xenografts BB Azad, A Lisok, S Chatterjee, JT Poirier, M Pullambhatla, GD Luker, ... Journal of Nuclear Medicine 57 (6), 981-988, 2016 | 33 | 2016 |
| In vivo evaluation of an engineered cyclotide as specific CXCR4 imaging reagent WG Lesniak, T Aboye, S Chatterjee, JA Camarero, S Nimmagadda Chemistry–A European Journal 23 (58), 14469-14475, 2017 | 28 | 2017 |
| Low-level endogenous PSMA expression in nonprostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging S Nimmagadda, M Pullambhatla, Y Chen, P Parsana, A Lisok, ... Journal of Nuclear Medicine 59 (3), 486-493, 2018 | 26 | 2018 |
Sridhar NimmagaddaProfessor of Radiology and Oncology, Johns Hopkins UniversityPatvirtintas el. paštas jhmi.edu
